Today I’m at the European Parliament, discussing cell & gene therapies, rather novel treatment options for terrible diseases. Incredible progress has been made by researchers!
The tricky bit: How medicines are regulated isn’t adapted to these novel types of treatments. Rules for clinical trials & approval don’t work well for #ATMPs.
Today experts are discussing which rules need to be adapted to bring these innovative treatments to patients faster.
#MEPsforATMPs #HorizonEurope #SciPol #HorizonEU